405
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Mirroring preeclampsia: the molecular basis of Ballantyne syndrome

ORCID Icon, ORCID Icon, , , &
Pages 768-773 | Received 09 Jun 2018, Accepted 11 Jul 2018, Published online: 06 Jan 2019

References

  • Ballantyne JW. The diseases and deformities of the foetus: an attempt towards a system of ante-natal pathology. Vol. 1. Edinburgh: Oliver & Boyd; 1892.
  • O’Driscoll DT. A fluid retention syndrome associated with severe iso-immunization to the rhesus factor. J Obstet Gynaecol Br Emp. 1956;63(3):372–374.
  • Gherman RB, Incerpi MH, Wing DA, et al. Ballantyne syndrome: is placental ischemia the etiology? J Matern Fetal Med. 1998;7(5):227–229.
  • Meekins JW, Pijnenborg R, Hanssens M, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101(8):669–674.
  • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
  • Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147–160.
  • O’Connor AE, McFarlane JR, Hayward S, et al. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod. 1999;14(3):827–832.
  • Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–1331.
  • Hirashima C, Ohkuchi A, Arai F, et al. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res. 2005;28(9):727–732.
  • Taylor RN, Varma M, Teng NN, et al. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 1990;71(6):1675–1677.
  • McKinney ET, Shouri R, Hunt RS, et al. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol. 2000;183(4):874–877.
  • Silver HM, Lambert-Messerlian GM, Star JA, et al. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 1999;180(5):1131–1137.
  • Krauss T, Kuhn W, Lakoma C, et al. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 1997;177(2):443–449.
  • Sánchez-Luceros A, Meschengieser SS, Marchese C, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis. 2003;14(7):647–651.
  • Lim R, Acharya R, Delpachitra P, et al. Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. Am J Obstet Gynecol. 2015;212(1):86.e1–86.12.
  • Hobson SR, Acharya R, Lim R, et al. Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. Pregnancy Hypertens. 2016;6(2):130–133.
  • Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.
  • Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(Suppl A):S38–S42.
  • Ramma W, Buhimschi IA, Zhao G, et al. The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis. 2012;15(3):333–340
  • Prefumo F, Pagani G, Fratelli N, et al. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin-to-twin transfusion syndrome. Prenat Diagn. 2010;30(4):378–379.
  • De Oliveira L, Sass N, Boute T, et al. sFlt-1 and PlGF levels in a patient with mirror syndrome related to cytomegalovirus infection. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):366–367.
  • Llurba E, Marsal G, Sanchez O, et al. Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome. Ultrasound Obstet Gynecol. 2012;40(3):367–369.
  • Goa S, Mimura K, Kakigano A, et al. Normalisation of angiogenic imbalance after intra-uterine transfusion for mirror syndrome caused by parvovirus B19. Fetal Diagn Ther. 2013;34(3):176–179.
  • Duthie SJ, Walkinshaw SA. Parvovirus associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol. 1995;102(12):1011–1013.
  • Zaki M, Greenwood C, Redman CW. The spontaneous reversal of pre-eclampsia associated with parvovirus-induced hydrops and the placental theory of pre-eclampsia: a case report. BJOG. 2003;110(12):1125–1126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.